Pathstone Holdings
XFOR icon

Pathstone Holdings’s X4 Pharmaceuticals XFOR Stock Holding History

Pathstone Holdings’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-421
Closed -$2.99K – 2349
2025
Q1 		$2.99K Hold
421
– – ﹤0.01% 2222
2024
Q4 		$9.27K Hold
421
– – ﹤0.01% 2297
2024
Q3 		$8.46K Hold
421
– – ﹤0.01% 2324
2024
Q2 		$7.33K Hold
421
– – ﹤0.01% 2301
2024
Q1 		$17.6K Hold
421
– – ﹤0.01% 2285
2023
Q4 		$10.6K Buy
+421
New +$10.2K ﹤0.01% 2192

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return